Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Ragnoli, M. Malerba, A. Radaeli, L. Buffoli, F. Lanzarotto, C. Ricci, A. Lanzini (Italy). Role of bronchial and alveolar exhaled nitric oxide in patients with ulcerative colitis (UC). Eur Respir J 2010; 36: Suppl. 54, 5429

Member's Comments

No comment yet.

Related content which might interest you: Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Screening with exhaled nitric oxide (ENO) may identify cases with on-going bronchial inflammation but not asthma symptoms Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001 Stability of exhaled nitric oxide (FENO) in patients with severe, steroid-dependent asthma Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 Alveolar concentration and bronchial output of exhaled nitric oxide in chronic rhinosinusitis Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007 Evaluation of exhaled nitric oxide and sputum eosinophils as markers of inflammation in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 176s Year: 2003 Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Phenotyping symptomatic asthma using proximal and peripheral exhaled nitric oxide Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Differential assessment of airway inflammation in chronic obstructive pulmonary disease (COPD) by measurements of exhaled nitric oxide (NO) derived from peripheral vs. central airways Source: Eur Respir J 2003; 22: Suppl. 45, 279s Year: 2003 Relationship between exhaled nitric oxide (eNO) and sputum eosinophils in severe asthma Source: Eur Respir J 2004; 24: Suppl. 48, 596s Year: 2004 Differential assessment of airway inflammation and anti-inflammatory treatment in asthma by measurements of exhaled nitric oxide (NO) derived from peripheral versus central airways Source: Eur Respir J 2003; 22: Suppl. 45, 449s Year: 2003 Domiciliary exhaled nitric oxide and eosinophilic airway inflammation in adults with asthma Source: Eur Respir J 2016; 48: 242-244 Year: 2016 Sputum inflammatory biomarkers and exhaled nitric oxide (FENO) in varying severity asthmatics Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006 Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Features of production nitric oxide at patients with a bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006 Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients Source: Eur Respir J 2009; 34: 138-144 Year: 2009 Changes in nitric oxide production in patients with bronchial asthma Source: Eur Respir J 2007; 30: Suppl. 51, 588s Year: 2007 Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms Source: Eur Respir J 2002; 20: 841-845 Year: 2002 Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model Source: Eur Respir J 2006; 28: 1236-1244 Year: 2006